Prescription abandonment climbs sharply as out-of-pocket costs rise, and prior authorization delays push more patients away. Showing cost and coverage at the point of prescribing could change whether patients ever start therapy.
News|Videos|May 19, 2025
Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1
Author(s)Richard Payerchin
Fact checked by: Todd Shryock
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Advertisement
The U.S. Food and Drug Administration has ruled GLP-1 RA drugs are no longer in shortage. That ruling affects how
Advertisement
Related to this article
Why advance directive conversations should not wait for the emergency department
Unfilled prescriptions and skipped referrals often reflect hidden logistical, financial and emotional work, not a lack of motivation. A behavioral scientist explains where patients drop off and how practices can close the gap in the first days after a recommendation.
Dengue is no longer just a travel disease in parts of Florida. Here’s how to test, treat and report it.
If Medicare cuts surgeon pay, it does not follow that Medicare should also cut reimbursement for primary care.
HFMA proposes ‘Declaration on Healthcare Affordability and Sustainability’ as physicians and patients feel the squeeze.
Blue Cross and Blue Shield of Texas is leaving Medicare Advantage, and several Florida systems are splitting with UnitedHealthcare. Here's what changes by state before the Dec. 7 deadline.
In three online experiments, adults who would have to pay for a procedure out of pocket were less likely to schedule it, and the anxiety the cost caused raised the pain they expected.
Advertisement
Advertisement
Trending on Medical Economics
1
Blue Cross and Blue Shield of Texas leaves Medicare Advantage as UnitedHealthcare splits with Florida health systems
2
The states where physician noncompetes can still be enforced in 2026
3
82% of Americans back a law requiring human review of AI claim denials, survey finds
4
Medically frail or not? A court ruling on Medicaid scrambles the answer for physicians, regulators
5